OTCMKTS:HYPMYHYPERA S A/S Stock Price, Forecast & News

$6.14

+0.30 (+5.14 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

$5.65

Now: $6.14▼

$6.14

50-Day Range

$4.70

MA: $5.33▼

$6.19

52-Week Range

$4.51

Now: $6.14▼

$9.53

Volume88,550 shs

Average Volume36,115 shs

Market Capitalization$3.88 billion

P/E Ratio11.23

Dividend Yield3.35%

Beta1.07

Hypera S.A. operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands. It also provides similars and generics under the Neo Química brand; dermocosmetics under the Lanidrant, Agecare, Dersab, Epidac, Epidrat, Episol, Hidramamy, Creme rejuvenecedor, Blancy, and Pielus brands; and food supplements and sweeteners. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. The company was founded in 2001 and is headquartered in São Paulo, Brazil.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for HYPERA S A/S.

2.6 Community Rank

Outperform Votes
HYPERA S A/S has received 154 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
HYPERA S A/S has received 142 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
HYPERA S A/S has received 52.03% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about HYPERA S A/S and other stocks. Vote “Outperform” if you believe HYPMY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HYPMY will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
HYPERA S A/S is a leading dividend payer. It pays a dividend yield of 3.35%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
HYPERA S A/S does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, HYPERA S A/S insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.22% of the stock of HYPERA S A/S is held by institutions.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of HYPERA S A/S is 11.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 13.50.
Price to Earnings Ratio vs. Sector
The P/E ratio of HYPERA S A/S is 11.23, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 11.88.
Price to Book Value per Share Ratio
HYPERA S A/S has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.10 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Toilet preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:HYPMY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.hypermarcas.com.br

Phone55-11-3147-7900

Debt

Debt-to-Equity Ratio0.05

Current Ratio2.73

Quick Ratio2.26

Price-To-Earnings

Trailing P/E Ratio11.23

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$978.11 million

Price / Sales3.97

Cash Flow$0.54 per share

Price / Cash Flow11.45

Book Value$3.58 per share

Price / Book1.72

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$309.06 million

Net Margins37.94%

Return on Equity14.73%

Return on Assets11.81%

Miscellaneous

Employees8,787

Outstanding Shares632,240,000

Market Cap$3.88 billion

Next Earnings Date8/3/2020 (Estimated)

OptionableNot Optionable

Receive HYPMY News and Ratings via Email

Sign-up to receive the latest news and ratings for HYPMY and its competitors with MarketBeat's FREE daily newsletter.

HYPERA S A/S (OTCMKTS:HYPMY) Frequently Asked Questions

How has HYPERA S A/S's stock been impacted by COVID-19 (Coronavirus)?

HYPERA S A/S's stock was trading at $6.98 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HYPMY stock has decreased by 12.0% and is now trading at $6.14. View which stocks have been most impacted by Coronavirus.

When is HYPERA S A/S's next earnings date?

HYPERA S A/S is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for HYPERA S A/S.

How were HYPERA S A/S's earnings last quarter?

HYPERA S A/S (OTCMKTS:HYPMY) announced its earnings results on Friday, April, 24th. The company reported $0.09 earnings per share for the quarter. The firm earned $184.06 million during the quarter. HYPERA S A/S had a net margin of 37.94% and a return on equity of 14.73%. View HYPERA S A/S's earnings history.

How often does HYPERA S A/S pay dividends? What is the dividend yield for HYPERA S A/S?

HYPERA S A/S declared a quarterly dividend on Monday, September 30th. Shareholders of record on Thursday, October 10th will be given a dividend of $0.04 per share on Friday, February 7th. This represents a $0.16 annualized dividend and a yield of 2.61%. The ex-dividend date of this dividend is Wednesday, October 9th. View HYPERA S A/S's dividend history.

Has HYPERA S A/S been receiving favorable news coverage?

News headlines about HYPMY stock have been trending very positive this week, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. HYPERA S A/S earned a coverage optimism score of 4.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news aboutHYPERA S A/S.

Who are some of HYPERA S A/S's key competitors?

Some companies that are related to HYPERA S A/S include Coty (COTY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), e.l.f. Beauty (ELF), Revlon (REV), United-Guardian (UG), 2050 Motors (ETFM), DS Healthcare Group (DSKX) and Mandom (MDOMF). View all competitors.

Who are HYPERA S A/S's key executives?

HYPERA S A/S's management team includes the following people:

Mr. Breno Toledo Pires de Oliveira, Chief Exec. Officer
Ms. Vivian Angiolucci, Chief Financial Officer
Mr. Carlos Roberto Scorsi, Chief Operating officer (Age 57)
Juliana Aguinaga Damião Salem, Chief Legal & Compliance Officer
Mr. Nelson José de Mello, Chief Corp. Relations Officer (Age 60)

What is HYPERA S A/S's stock symbol?

HYPERA S A/S trades on the OTCMKTS under the ticker symbol "HYPMY."

How do I buy shares of HYPERA S A/S?

Shares of HYPMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is HYPERA S A/S's stock price today?

One share of HYPMY stock can currently be purchased for approximately $6.14.

How big of a company is HYPERA S A/S?

HYPERA S A/S has a market capitalization of $3.88 billion and generates $978.11 million in revenue each year. HYPERA S A/S employs 8,787 workers across the globe.

What is HYPERA S A/S's official website?

The official website for HYPERA S A/S is www.hypermarcas.com.br.

How can I contact HYPERA S A/S?

HYPERA S A/S's mailing address is AV. MAGALHAES DE CASTRO 4800 - 24¿ ANDAR EDIFICIO CONTINENTAL TOWER, SAO PAULO D5, 05676-120. The company can be reached via phone at 55-11-3147-7900 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff